Rheumatic diseases are frequently noticed in females
particularly in childbearing years.
The relevance of female sex hormones like estrogens
in the pathogenesis of the rheumatic diseases’ initiation and development has
been confirmed by their increased prevalence in females. The
fact that periods of altered hormonal status like menstrual cycle, pregnancy,
menopause and use of oral contraceptives have an influence on rheumatic
diseases is now coming to light.
Rheumatic diseases in pregnancy may improve, worsen from current state
or remain unchanged. Studies indicate that rheumatoid arthritis improves during
pregnancy and flares up following delivery. However, patients with ankylosing
spondylitis are not markedly affected by pregnancy. In case of Systemic Lupus Erythematosus (SLE), pregnancy could result in the disease remaining active or in a flare up of the disease.
The fetus may also suffer from complications of lupus including congenital
heart disease due to spread of antibodies from the mother to the fetus. Primary
anti-phospholipid antibody syndrome (APS) could result in recurrent pregnancy
losses. The prognosis however has improved with the use of low dose aspirin and
anticoagulation. SLE and APS also increase the risk of pre-eclampsia in the
mother. Systemic sclerosis (SSc) could result in premature delivery of the
fetus, though patients with stable and mild disease could have an uneventful
pregnancy. Patients with vasulitis like Behcet’s syndrome, Takayasu arteritis
and Churg-Strauss syndrome usually have a successful pregnancy and delivery if
the disease is well controlled.
Besides pregnancy, fertility in males as well as
females is affected by rheumatic diseases.
The prediction about the status of pregnancy outcome
(like fetal growth retardation, pre eclampsia) and their relation with
rheumatic diseases is being studied in the
PROMISSE (predictors of pregnancy
outcome: biomarkers in antiphospholipid syndrome and systemic lupus
erythematosus) study.
Preconceptional counseling as well as
well-coordinated medical and obstetric care is essential for improving the
outcomes of pregnancy in patients suffering from autoimmune diseases. The
aftermaths of the rheumatic disorders as well as of the medications taken for
the disease on children also requires adequate attention.
Source: Pregnancy and Reproduction
in Autoimmune Rheumatic Disease. Monika Ostensen; Antonio Brucato; Howard Carp;
Christina Chambers; Radboud J. E. M. Dolhain; et al. Rheumatology
2011;50(4):657-664.
Source-Medindia